tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

0RA9 Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Pre-Earnings0RA9 Earnings Report this Week: Is It a Buy, Ahead of Earnings?
12h ago
Abivax SA: Buy Rating Affirmed Amid Promising Phase 3 Data and Strategic Growth Prospects
PremiumRatings
Abivax SA: Buy Rating Affirmed Amid Promising Phase 3 Data and Strategic Growth Prospects
3d ago
ABVX
Optimistic Buy Rating for Abivax SA: Potential of Obefazimod Amid Safety and Financial Considerations
PremiumRatings
Optimistic Buy Rating for Abivax SA: Potential of Obefazimod Amid Safety and Financial Considerations
9d ago
ABVX
Abivax initiated with a Buy at Truist
PremiumThe Fly
Abivax initiated with a Buy at Truist
19d ago
ABVX
Caterpillar upgraded, Elf Beauty downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Caterpillar upgraded, Elf Beauty downgraded: Wall Street’s top analyst calls
1M ago
FN
CAT
Positive Outlook for Abivax SA: Obefazimod’s Potential in Crohn’s Disease Drives Buy Rating
PremiumRatingsPositive Outlook for Abivax SA: Obefazimod’s Potential in Crohn’s Disease Drives Buy Rating
1M ago
ABVX
Abivax initiated with an Outperform at Wolfe Research
Premium
The Fly
Abivax initiated with an Outperform at Wolfe Research
1M ago
ABVX
Abivax announces patient-reported outcomes from ABTECT trial
Premium
The Fly
Abivax announces patient-reported outcomes from ABTECT trial
1M ago
ABVX
Abivax initiated with an Overweight at Barclays
PremiumThe Fly
Abivax initiated with an Overweight at Barclays
2M ago
ABVX
Abivax price target raised, named a ‘Best Idea’ at Guggenheim
PremiumThe Fly
Abivax price target raised, named a ‘Best Idea’ at Guggenheim
2M ago
ABVX
Abivax price target raised to $120 from $112 at BTIG
PremiumThe Fly
Abivax price target raised to $120 from $112 at BTIG
2M ago
ABVX
Abivax’s Obefazimod: Promising Clinical Results and Market Potential Drive Buy Rating
PremiumRatings
Abivax’s Obefazimod: Promising Clinical Results and Market Potential Drive Buy Rating
2M ago
ABVX
Abivax announces ABTECT 1, ABTECT 2 trials met primary endpoint
PremiumThe FlyAbivax announces ABTECT 1, ABTECT 2 trials met primary endpoint
2M ago
ABVX
Promising Phase 2b Results and Competitive Positioning Support Buy Rating for Abivax’s Obefazimod
Premium
Ratings
Promising Phase 2b Results and Competitive Positioning Support Buy Rating for Abivax’s Obefazimod
3M ago
ABVX
Abivax price target raised to $114 from $95 at Citizens JMP
Premium
The Fly
Abivax price target raised to $114 from $95 at Citizens JMP
3M ago
ABVX
One new option listing on September 18th
PremiumThe Fly
One new option listing on September 18th
3M ago
ABVX
Abivax price target raised to $101 from $71 at Morgan Stanley
PremiumThe Fly
Abivax price target raised to $101 from $71 at Morgan Stanley
3M ago
ABVX
Promising Outlook for Abivax SA: Buy Rating Supported by Strong Clinical Results and Financial Position
PremiumRatings
Promising Outlook for Abivax SA: Buy Rating Supported by Strong Clinical Results and Financial Position
3M ago
ABVX
0RA9 Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
0RA9 Upcoming Earnings Report: What to Expect?
3M ago
Abivax’s Promising Phase 2b Study on Obefazimod for Crohn’s Disease
PremiumCompany AnnouncementsAbivax’s Promising Phase 2b Study on Obefazimod for Crohn’s Disease
4M ago
0RA9
Abivax’s Promising Phase 2b Study on Obefazimod for Crohn’s Disease: Market Implications
Premium
Company Announcements
Abivax’s Promising Phase 2b Study on Obefazimod for Crohn’s Disease: Market Implications
4M ago
0RA9
Abivax’s Promising Phase 2b Study on Obefazimod for Crohn’s Disease: A Potential Game-Changer?
Premium
Company Announcements
Abivax’s Promising Phase 2b Study on Obefazimod for Crohn’s Disease: A Potential Game-Changer?
4M ago
0RA9

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >